Meril Life Sciences, a leading global med-tech company specializing in cardiovascular and structural heart solutions, marked ...

Meril Life Sciences, a leading global med-tech company specializing in cardiovascular and structural heart solutions, marked ...

Scientists at Queen Mary University of London are developing a newly invented material for creating artificial heart valves as effective as native valves. Heart valves show an incredibly complex ...

The Myval THV series, known for its innovative contributions to transcatheter aortic valve replacement (TAVR) procedures, ...

A large new population study of men over 45 indicates insulin resistance may be an important risk factor for the development of the world's most common heart valve disease -- aortic stenosis (AS).

Scientists at Queen Mary University of London are developing a newly invented material for creating artificial heart valves as effective as native ...

Edwards Lifesciences (NYSE:EW) today announced one-year data highlighting strong performance from its Sapien 3 Ultra Resilia ...

LONDON--Edwards Lifesciences (NYSE: EW) today announced one-year data highlighting the continued outstanding performance of its SAPIEN 3 Ultra RESILIA valve. The data were presented at PCR London ...

Meril Life Sciences, a leading global med-tech company specializing in cardiovascular and structural heart solutions, marked a significant milestone with the launch of its Myval Octapro Transcatheter ...